BackOmega Diagnostics Group PLC Overview
Omega Diagnostics Group PLC

Omega Diagnostics Group PLC Return on Equity

Valuation check: ODX.L's ROE is -35.85%, below the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

-35.85%

Return on Equity

-35.85%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Omega Diagnostics Group PLC (ODX.L) FAQ

The latest ROE for ODX.L is -35.85%. That is below the sector sector average of 11.3%. Investors often review this figure alongside Omega Diagnostics Group PLC's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, ODX.L currently prints -35.85% for ROE, while the sector average sits near 11.3%. That is roughly 417.4% below the sector mean. Large gaps often invite a closer look at Omega Diagnostics Group PLC's growth, margins, and balance sheet.

Return on Equity shows how effectively Omega Diagnostics Group PLC converts resources into returns. At -35.85%, ODX.L may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ODX.L's ROE (-35.85%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.